Amedica Corporation (NASDAQ:AMDA) shares fell -2.65% in last trading session and ended the day at $0.11. AMDA Gross Margin is 63.10% and its has a return on assets of -73.80%. Amedica Corporation (NASDAQ:AMDA) quarterly performance is -64.05%.
A. Lombardi, from Vice President, Finance and Chief Accounting Officer, to the position of Chief Financial Officer (principal financial officer and principal accounting officer). Mr. Lombardi served as the Amedica Corporation (NASDAQ:AMDA)’s Vice President Finance and Principal Accounting Officer from January 2015 to January 3, 2016.
Progress Software Corporation (NASDAQ:PRGS) ended the last trading day at $22.60. Company weekly volatility is calculated as 2.77% and price to cash ratio as 5.20. Progress Software Corporation (NASDAQ:PRGS) showed a weekly performance of -5.68%.
Progress (NASDAQ: PRGS), announced results for its fiscal fourth quarter and fiscal year ended November 30, 2015. Revenue in the quarter was $112.7 million compared to $97.9 million in the same quarter last year, a year over year increase of 15% on an actual currency basis and 21% on a constant currency basis. On a non-GAAP basis, revenue was $115.4 million compared to $97.9 million in the same quarter last year, an increase of 18% on an actual currency basis and 24% on a constant currency basis.
On 12 January, Encore Wire Corp. (NASDAQ:WIRE) shares fell -0.83% and was closed at $34.70. WIRE EPS growth in last 5 year was 61.90%. Encore Wire Corp. (NASDAQ:WIRE) year to date (YTD) performance is -6.39%.
Encore Wire Corporation (NASDAQ Global Select: WIRE) announced that the Company’s Board of Directors has declared a cash dividend. Daniel L. Jones, Chairman, President and Chief Executive Officer of Encore Wire Corporation, said, “This two-cent per share dividend will be paid on January 22, 2016 to stockholders of record at the close of business on January 8, 2016.
Affimed N.V. (NASDAQ:AFMD) shares fell -1.56% in last trading session and ended the day at $4.42. AFMD has a return on assets of -35.90%. Affimed N.V. (NASDAQ:AFMD) quarterly performance is -34.42%.
Wells Fargo began coverage on shares of Affimed NV (NASDAQ:AFMD) in a report published on Thursday morning, The Fly reports. The firm issued an outperform rating on the biopharmaceutical company’s stock.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) caters to the Healthcare space. Its weekly performance is -16.75%. On the last day of trading company shares ended up at $6.51. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving average (SMA50) is -0.03%.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that Robert Mulroy, President and CEO, presented at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 at 2:30 p.m. (PT) at the Westin St. Francis Hotel in San Francisco.
Leave a Reply